combin aetna creat franchis
protect narrow econom moat
updat forecast estim
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research
estim
price data
rate updat
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
spent better part last decad posit
leader within healthcar servic -- acquisit
caremark omnicar recent aetna defin
strateg direct combin lead pbm retail
pharmaci top manag care franchis form three pillar
think posit firm better compet
consolid healthcar servic sector next year
cost advantag underli network effect support
firm excess econom return set strengthen
integr aetna continu come year think
cost sale synergi like exceed initi expect
firm begin serv custom lower all-in cost
rival increas attract combin medic
said think investor increasingli cautiou
evalu potenti issu aris transact
high price paid signific debt incur increas
oper risk otherwis larg stabl franchis
view follow write-down omnicar due
poor financi perform think littl room error
ensur aetna acquisit see success complex
accentu increas focu washington toward
chang current drug price paradigm open door
potenti market disrupt caremark pbm industri
final expect concern around healthcar reform pick
come quarter elect cycl begin
unfold believ firm econom moat help protect
policy-driven volatil maintain large-scal
disrupt low-prob event think like
outcom would includ privat servic provid play role
polici solut nation rise cost healthcar
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
follow acquisit aetna provid
integr healthcar servic offer member legaci
combin largest pharmaci benefit manag process nearli
billion adjust claim annual sizabl retail pharmaci boast
organ roughli million member put firm stronger
foot within payer industri posit better lower overal
cost client
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
follow slightli weaker outlook expect
firm first full-year own aetna lower fair
valu estim per share impli roughli
time updat estim adjust
earn ebitda respect firm appear deepli
under-valued despit forecast larg reflect
continu headwind long pressur
retail segment forecast overal revenu growth
set averag annual come five year
driven growth store count same-stor comp
averag midsingl digit bulk driven
script volum persist headwind
prescript reimburs pharmaci model
approxim basis-point step-down segment margin
associ weak compani omnicar
institut pharmaci subsequ improv
margin structur busi
pbm expect revenu grow annual
clip driven growth claim off-set price pressur
mail order network pharmaci channel
consequ on-going price headwind assum
gross margin oper profit per claim
continu declin rate roughli per year
leav segment oper margin histor trough
termin forecast year
final aetna expect posit sale environ
underpin combin medic pharmaci benefit
gener membership growth
time assum segment margin structur
somewhat defend help manag outlin
opportun around cost synergi associ
assumpt result consolid revenu growth
annual consolid
ebitda margin remain near forecast
period follow debt reduct next two year
assum return share repurchas help gener
roughli ep growth long run
given scale divers oper give
medium uncertainti rate bull-cas scenario
assum firm abl grow firm-wide revenu rate
roughli basi point ahead base-cas
expect specif bulk upsid
revenu forecast driven manag price
pressur across enterpris script price
pharmaci pbm face shallow declin
base case model addit view margin pressur
within firm retail pbm segment
manag less pronounc declin
busi insur oper assum modest
margin expans integr synergi come ahead
expect oper expens growth fall
margin expand roughli basis-point forecast
period result fair valu estim per share
time estim adjust ep
bear case outlook isnt absolut worst-cas
scenario think reason encapsul
on-going weak perform compani
instanc normal revenu growth enterpris fall
slightli ahead annual also assum price
margin pressur firm three busi
result segment margin emb trough-lik
assumpt perpetu consolid ebitda margin
compani fall roughli basis-point
weakest
profit experienc firm decad
expect fair valu estim fall per
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
caremark pbm
driven pharmaci relationship patient
compani dispens one quarter prescript
fill outsid hospit help support econom
profit leverag fix cost creat synergi
order creat
cost-advantag pharmaci network within pbm
segment firm clear number one adjud
nearli billion adjust script annual addit
pbm abil consolid buy power help receiv
discount pharmaci drug manufactur
client caremark perenni low-cost
provid due size relationship pharmaci
locat view histor uniqu
combin asset think
leverag ad aetna mix pbm industri
consolid three major player
annual retent rate typic establish
three-year servic contract plan employ client
think establish weak switch cost
busi howev convinc moat
sourc would stand absent cost advantag
think strongli defin competit advantag
industri
combin pbm retail pharmaci help
creat uniqu offer help keep cost
pbm client creat valu enterpris
instanc mainten choic offer give member
option fill script mail order pharmaci
retail locat cost mail order script
help keep patient network regardless
prefer dispens method keep cost
plan sponsor think similar synergi emerg
aetna minuteclin asset own
think chang plan design encourag patient
seek minuteclin care low-acu ailment
ultim creat benefit patient
plan sponsor lower cost across board
share impli time estim adjust
ep ebitda respect
support scale-deriv cost advantag aid firm
maintain econom profit time
strateg addit aetna creat meaning cost
synergi also improv compani firm-wide
product offer combin entiti close
resembl asset mix wide-moat
view right path compani pursu
integr medic pharmaceut benefit
maintain access low-cost site care seem
direct path toward reduc cost care
client appear well way toward build
franchis focus opportun
three busi segment quit uniqu
think three reli cost advantag support
narrow econom moat pharmaci busi
front-of-stor retail busi somewhat undifferenti
like no-moat bulk segment revenu
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
manag intend remodel exist
locat initi geographi higher concentr
aetna member order cater special
patient need think logic extens
strategi compani invest minuteclin
step recent year remain signific
opportun remodel exist store expand urgent
care footprint alreadi largest retail clinic chain
wide margin market share clinic count
recent addit aetna insur asset also help
support narrow moat view contend
profit back cost advantag network effect
aetna repres fifth
measur premium written like third
fourth largest membership given sizabl fee-bas
enrol mix advantag thought two
way relat back size insur book
busi first larger membership base allow
greater central fix cost leverag increas profit
potenti margin member overal enterpris
second larger membership base allow greater
negoti leverag versu provid insur
need creat plan network allow lower medic
cost per member opportun lower premium
improv benefit offer secur enrol growth
rare instanc healthcar system focus build
local scale shift balanc power
relationship given much higher
level
concentr found industri larg think
scale frequent tip insur favor
network effect also play intertwin role
patient payer provid incumb plan
enrol grow relationship three
entiti becom valuabl time patient
becom rel afford plan invest
broader swath benefit member payer
expand enrol allow greater per-memb
profit attract offer either
better price entic benefit packag
provid particip expand plan network
provid access greater patient volum key
compon profit busi high fix cost
short run dynam creat barrier entri
would-b competitor put togeth attract
price provid network new geographi prohibit
difficult without membership pool vice versa
think sourc present aetna
less convinc network effect moat sourc would stand
support econom profit
enterpris like weak network effect
associ retail pharmaci busi appear
meaning less moatworthi network
associ manag care express script exclus
walgreen loss expect
along loss network statu prime
therapeut suggest us pharmaci
network provid less overal valu compar
provid relationship manag care somewhat
intuit patient like much indiffer
fill prescript either walgreen
would switch primari care
provid due network disput
think pursu right strategi build
integr servic provid abl add
valu client sharehold cross-sel medic
pharmaci benefit provid low-cost retail mail
drug dispens get better util
urgent care asset aetna acquisit put
equal foot industri leader
give firm right combin asset better lower
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
period price asset rel high
leav consolid return invest capit
margin ahead firm cost capit howev
think return exclud goodwil indic
firm organ return increment capit go forward
metric consist mid high teen leav us
confid moat trend assess
cost care patient plan sponsor
think underli moat sourc attribut
strengthen result strateg
reshap follow acquisit aetna posit
exist cost advantag like improv
gain greater control integr cost medic
pharmaceut servic sell plan employ
sponsor opportun increas narrow-network
util within pharmaci improv site-of-car usag
minuteclin
combin cost
pharmaceut medic benefit integr
cost-sel initi creat compel case
strengthen competit posit next five year
addit suggest network effect like
arent widespread enough support narrow moat rate
isol think network effect associ
pharmaci medic benefit manag like
strengthen aetna caremark come togeth
umbrella extent pharmaci
minuteclin asset see increas util aetna
plan design think valu network
end patient plan sponsor like grow alongsid
member particip network success failur
strategi depend well convinc
plan sponsor take restrict access order
legaci busi seen lower return
capit insurance-focus peer due
higher capit intens associ retail pharmaci
busi adjust leas oblig also
note invest capit growth larg driven
acquisit think value-addit
enterpris acquisit caremark
omnicar pharmaci aetna
account nearli net invest capit growth
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
oth firm combin aetna put
compani much attract competit
posit industri move toward prefer
integr servic offer
orec polici initi suggest potenti
chang exist rebat structur drug
distribut may risk chang would like
ocv ownership largest nation pbm provid
substanti negoti
leverag cost
advantag claim process allow best-
oth bulk insur membership growth
come year stem cohort lower-margin
headwind insur profit
oinvestor benefit meaning cost
sell synergi associ combin
lead medic benefit busi largest
pbm retail pharmaci network countri
ohealthcar reform like recur topic
throughout upcom elect cycl
could creat increas stock volatil pose real
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
financi posit remain reason
take roughli billion increment debt acquir
aetna think manag capit prioriti worth
watch close follow transact close
late estim firm pro-forma leverag ratio
fall north time versu histor leverag rang
time manag outlin de-lever
path believ achiev put compani
track reach debt-to-adjust ebitda ratio
time come two year assum growth
firm per share dividend pay-out addit
share repurchas combin firm
gener plenti cash reduc debt burden sizabl
amount next year anticip return
regular dividend growth buy-back activ beyond
give medium uncertainti rate follow
close aetna acquisit compani ownership
lead pharmaci benefit manag sizabl retail
pharmaci footprint top insur help de-risk
volatil underli cash flow increas
opportun firm find cost revenu
synergi segment time said
regulatori risk remain ever-pres healthcar
payer provid administr push
increas transpar healthcar marketplac
particularli relat drug channel pose
potenti risk firm pbm retail oper
give us comfort firm abil weather
potenti chang regul push structur
chang price system throughout drug distribut
would like creat headwind growth profit
shorter term hand encourag
opportun compani marri newli
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
acquir insur asset lead pbm win new
busi serv insur client overal lower
price point think increas competit
firm offer like modestli improv
sticki client relationship
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
repres date owner name posit common share held report holder issuer
share
fund
share
fund
although intend keep eye on-going capit
alloc prioriti event suggest
histor acquisit less stellar
said think ceo larri merlo done
otherwis admir job lead busi ever sinc
pharmacist train merlo involv
sinc instrument firm
transit true healthcare-focus organ
think aetna transact like defin time
ceo expect success importantli mani
key aetna leader stay follow transact
includ firm presid karen lynch lead
busi unit former compani ceo mark bertolini
join board director
addit strong leadership team enterpris
think board put place strong compens
program align incent manag
sharehold bulk merlo compens driven
equiti incentive-bas award comprehens
set goal think consist build
intrins valu firm annual cash bonus tie
firm-wide oper profit along custom satisfact
measur pbm retail segment equiti
grant focus three-year measur return net
asset similar focu return capit rel
total sharehold return addit board recent
introduc perform stock unit vest three
year tie ebitda target
signific factor assess
appreci firm polici separ role board
chairman ceo
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
disappoint weak outlook valuat
narrow-moat report fiscal result
larg met expect legaci busi
addit aetna creat volatil report
number howev highlight guidanc
fell short profit expect across board
miss prevail consensu estim even wider
margin adjust model may tweak per
share fair valu estim continu view firm
deepli under-valued despit weaker outlook
appear oner transit year
origin anticip share repres compel valu
current market price impli less time adjust
good portion shortfal stem on-going
weak firm long-term-car busi led
depress profit
manag took two separ goodwil write-down
cours result end-market disrupt
affect skill nurs custom total nearli half
amount spent acquir omnicar
disappoint outcom sharehold plan
leav standard stewardship rate place
pharmaci combin lack gener launch
weaker brand drug inflat expect
culmin overal segment oper profit set fall
high-single-digit rate come year
pharmaci benefit manag side busi
perform close align model
alreadi call structur margin pressur
come year said
affect increment cost need coordin
firm new partnership said
decis bring in-hous pbm oper next
year partial off-set long-term benefit
aetna transact appear perform reason
well short month sinc deal close
manag alreadi indic initi million
target cumul cost synergi like conserv
enrol appear set grow well ahead market rate
nearli driven gain medicar
advantag commerci book busi long
run contend firm integr medic
pharmaceut benefit make much
competit offer either would individu
underpin posit trend rate enterpris
impli assumpt embed current market price
unreason appear pessimist us given
competit posit broadli speak bake
littl consolid revenu growth structur
margin declin busi segment
acquisition-rel cost synergi get model roughli
line stock price low rang
slightli wors bear-cas valuat scenario
imposs outcom think current
expect provid attract margin safeti
investor rel low bar compani beat
come year
hh propos chang drug rebat system pbm
outlook risk feb
depart human servic propos
rule jan aim untangl opaqu price
incent scheme exist current rebat
system prescript drug rule attempt forc
pass-through drug manufactur discount plan
beneficiari point sale expressli exclud
safe-harbor provis antikickback statut
discount paid medicar part medicaid
managed-car organ net effect pharmaci
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
benefit manag econom theoret
minim face valu rebat government-
sponsor plan alreadi pass one
way anoth think bigger risk potenti
spillov privat market
today bulk rebat throughout system use
buy plan premium lower monthli payment
expens higher co-insur requir
member cost-shar arrang typic struck
manufactur gross net price
altern propos hh forc plan appli
rebat counter lower out-of-pocket requir
beneficiari trade-off higher monthli premium
expect pbm industri loudest critic
polici transit rebateless system would difficult
uncertain mani unintend consequ
associ replac nationwid price system
industri
stakehold come month perceiv
pitfal could affect variou link suppli chain
like becom clear intend
chang project fair valu estim
compani cover result propos
watch progress close better determin
payment -- conclus govern ultim seem
agre depart initi goal implement
chang effect jan think timelin
probabl optimist
polici chang like would benefit minor
sickest highest-cost patient accord hh
beneficiari enrol part would see net
reduct total drug cost nearli
popul would probabl see premium
increas greater save gener
pharmaci counter aggreg cost beneficiari
program whole would declin period
remain receiv coverag low-
incom subsidi program probabl wouldnt see much
individu would see overal benefit aggreg
spend could actual increas next decad due
higher outlay feder govern accord
propos increas direct subsidi payment
surpass save lower reinsur spend
beneficiari catastroph phase coverag lower
cost-shar requir low-incom
subsidi conclus back scenario analys
compil hh
govern math line mani
compani space say follow
request inform topic center
medicar medicaid servic late
proactiv provid pos arrang
fulli insur member seen littl interest
pos part offer given sticker shock
higher premium express script suggest
lower price beneficiari would off-set
higher premium
pbm face risk propos two key
reason view first adjust accept
safe harbor creat inher legal risk
oper affect addit hh explicitli
refer long-standing polici disallow price
reduct offer payer avail
medicar medicaid may hamstr
effect pbm formulari tier potenti
polici open door chang commerci
market seem rel straightforward result hh
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
intend defer congress regulatori author
relat privat insur wait see
pbm intend step around languag await
inquiri congression committe path
toward wide-rang chang seem rel clear
propos implement written
second along chang type discount
allow industri rule intend exclud
nonreb pbm servic fee tie list price volum
metric safe-harbor provis hh would
expressli permit flat-fe arrang attempt
better align incent among plan sponsor pbm
drug manufactur potenti magnitud chang
unclear think neg pbm profit
rule unconstitut district court
near-term impact fundament dec
dec judg reed connor northern district
texa issu rule effect declar patient
protect afford act
unconstitut assum littl chang
compani cover healthcar sector
near term rule like make way
appeal process surpris see
case third appear make front
 suprem court potenti timelin final
basi decis find root congress
elimin shared-respons financi penalti
accompani passag tax cut job act
late last year short judg connor found individu
mandat essenti insever provis
congress decis elimin enforc
tax penalti law render entireti
legisl unconstitut logic follow
 suprem court decis upheld
constitut congress power taxat
view healthcar provid sector at-risk
stem chang prevail healthcar
legisl whether chang individu coverag
roll-back medicaid expans higher uninsur
rate unequivoc equat pressur hospit margin
payer perspect trade-off littl less clear
although medicaid-focus insur like feel
bulk enrol loss
intend make chang moat rate fair
valu estim result decis continu
monitor case make way appel
court come month outcom timelin
uncertain make meaning chang
assumpt earli day addit wildcard
potenti legisl action muddi
ultim financi penalti carri
insur coverag set end jan
understand feder govern intend
maintain statu quo appeal process
insur alreadi lock rate propos
earliest like see potenti effect
rule premium polici offer slate
open enrol season
remain track close
report solid quarter reiter
fair valu estim narrow-moat pbm firm
report robust increas revenu segment
effort becom prefer pharmaci restrict
network drove retail top line good gain client win
client member growth bolster pbm oper
impress also abl expand gross margin
basi point -- driven larg strong gross profit
perform firm pbm oper howev
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
forc discount
retail segment produc decreas gross
margin
gener
pharmaceut product order obtain prefer
pharmaci statu sever pbm pharmaci network
addit firm central cost percentag
revenu increas manag state make
invest use fund save recent tax
reduct invest temper
quarter result believ help lay ground
work smoother integr aetna asset
transact close manag state expect close
deal approv five remain state
team feel confid soon receiv approv
remain state final stage
negoti key jurisdict
previous state believ aetna
overal strategi signific potenti drive materi
econom profit come decad
combin new cvs/aetna healthcar servic firm
fundament chang healthcar provid
individu ultim view new entiti
healthcar servic behemoth infrastructur sell
insur manage/treat member everi aspect
healthcar treatment regimen lower cost
perspect capabl key asset
servic member chronic recur medic
issu -- especi key medicar insur cohort
firm abl leverag signific retail
footprint power pbm better control
cost treat patient firm also abl
leverag aetna larg insur membership book solid
underwrit plan design capabl sale
market expertis believ combin
oper give new cvs/aetna entiti key
advantag bring cost treat tradit
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
